Alexander disease, also known as fibrinoid leukodystrophy, is a rare genetic disorder that affects the nervous system. It is a type of leukodystrophy, a group of disorders that primarily affect the brain’s white matter and the myelin that surrounds nerve fibers. Myelin acts much like insulation around electrical wires, helping nerve signals travel efficiently. In Alexander disease, abnormal changes in a protein called glial fibrillary acidic protein (GFAP) cause damage to supporting cells of the nervous system called astrocytes. This can interfere with the normal development and function of the brain and spinal cord. The disease can occur at any age. Historically, Alexander disease was divided into infantile, juvenile, and adult forms according to the age at which symptoms began. Today, it is more commonly understood as a spectrum of disease with different clinical features depending on the age of onset.
The symptoms and severity of Alexander disease can vary considerably from person to person. Early-onset forms generally tend to be more severe. Common signs and symptoms may include:
Developmental delay
Loss of previously acquired developmental skills or mental regression
Learning difficulties or intellectual disability
Seizures
Muscle stiffness and restricted movement (spasticity)
Problems with coordination and balance (ataxia)
Impaired mobility
Muscle weakness
Speech and language difficulties
Difficulty swallowing (dysphagia)
Problems with coughing and clearing secretions
Breathing difficulties
Feeding difficulties
Failure to thrive or poor weight gain
Enlarged head size (macrocephaly), particularly in some children with early-onset disease
Hydrocephalus, or an abnormal accumulation of cerebrospinal fluid in the brain
Nausea and vomiting
Sleep disturbances
Abnormal eye movements
Problems with bladder or bowel control, particularly in later-onset disease
Because Alexander disease affects the brain and, in some cases, the spinal cord, neurological problems are prominent. Children with early-onset disease may experience seizures, developmental delay, increasing muscle stiffness, difficulty walking, and loss of motor skills. People with juvenile- or adult-onset Alexander disease may experience problems with balance, coordination, speech, swallowing, or movement. Some individuals may also develop symptoms involving the autonomic nervous system, which controls involuntary functions such as blood pressure, sweating, bladder function, and digestion.
Alexander disease is caused by a pathogenic variant (mutation) in the GFAP gene. The GFAP gene provides instructions for making glial fibrillary acidic protein, an important protein found primarily in astrocytes. Abnormal GFAP protein can accumulate inside astrocytes, leading to the formation of characteristic abnormal structures known as Rosenthal fibers. These changes interfere with the normal functioning of astrocytes and contribute to damage within the nervous system. Most cases of Alexander disease result from a new (de novo) GFAP variant, meaning the genetic change occurs for the first time in the affected individual and was not inherited from either parent. Alexander disease is generally inherited in an autosomal dominant manner. However, because most cases result from new genetic changes, a person may develop the disorder even when there is no previous family history.
Although Alexander disease is a genetic disorder, most affected individuals do not have an affected parent. This is because the GFAP variant usually occurs spontaneously. If a person with Alexander disease has a child, however, there is a 50% chance with each pregnancy of passing the disease-causing GFAP variant to the child, regardless of sex. Genetic counseling can help affected individuals and families understand inheritance patterns and potential risks to relatives.
Adult-onset disease can have a different pattern of symptoms and may progress more slowly. Common manifestations include:
Difficulty walking
Poor balance and coordination
Speech problems
Difficulty swallowing
Abnormal movements
Muscle stiffness
Sleep disturbances
Autonomic dysfunction
Respiratory problems
Some people with adult-onset disease may initially be diagnosed with another neurological condition because the symptoms can resemble those of other disorders.
A brain MRI is particularly important in the evaluation of suspected Alexander disease. Certain characteristic patterns of abnormalities in the brain and, in some cases, the spinal cord can support the diagnosis. MRI findings may include changes in the brain’s white matter and abnormalities in specific regions of the nervous system.
A blood or saliva sample can be analyzed to look for a disease-causing variant in the GFAP gene. Identification of an appropriate pathogenic GFAP variant can confirm the diagnosis in many cases.
There is currently no cure that reverses the underlying genetic cause of Alexander disease. Treatment focuses on managing symptoms, preventing complications, and maintaining the person’s quality of life. Treatment may include:
Speech-language therapists can help with communication difficulties and assess swallowing problems. Appropriate management may reduce the risk of choking and aspiration.
Children or adults who have severe feeding or swallowing difficulties may require specialized nutritional support. In some cases, tube feeding may be considered.
People with swallowing or muscle-control problems may be at increased risk of respiratory complications. Monitoring and supportive respiratory treatment may therefore be necessary.
If hydrocephalus develops and requires treatment, a neurosurgical procedure such as placement of a shunt may sometimes be considered. Because symptoms differ considerably between individuals, treatment should be individualized and coordinated by a multidisciplinary medical team.
The outlook for Alexander disease varies depending largely on the age of onset and severity of disease. Early-onset disease is generally more severe and may progress rapidly. Later-onset forms can have a slower progression, although significant neurological disability can still develop. Alexander disease can affect movement, communication, swallowing, feeding, and breathing. Regular medical monitoring can help identify complications early and provide appropriate supportive care.
The primary specialist for suspected or diagnosed Alexander disease is a:
Neurologist, particularly a pediatric neurologist for children
Clinical geneticist or genetic counselor for genetic evaluation and family counseling
Depending on the symptoms, additional specialists may include:
Neurosurgeon — for complications such as hydrocephalus
Physical therapist — for mobility and muscle stiffness
Occupational therapist — for assistance with daily activities
Speech-language therapist — for speech and swallowing problems
Pulmonologist — for significant breathing or respiratory problems
Gastroenterologist or nutrition specialist — for feeding and nutritional difficulties
Sleep specialist — for significant sleep-related problems
An endocrinologist is not routinely involved in the diagnosis or treatment of Alexander disease unless the individual has a separate endocrine condition.
Alexander disease cannot currently be prevented because it is caused by a genetic change. Since most cases arise from new GFAP variants, there is usually no known action that could have prevented the condition. Families with a known history of Alexander disease may benefit from genetic counseling to understand inheritance and reproductive risks.
No. Alexander disease is a genetic neurological disorder and cannot be transmitted from one person to another through contact, food, air, or other ordinary means.
Most cases result from a new genetic change and occur in people with no family history. However, the condition can be inherited in an autosomal dominant manner when an affected person passes the altered GFAP gene to a child.
There is currently no established cure that eliminates the underlying genetic cause. Treatment is mainly supportive and aimed at controlling symptoms and complications.
The prognosis varies greatly. Severe early-onset disease can be life-threatening, while adult-onset forms may progress more slowly. Individual outcomes depend on the age of onset, severity, and complications.
Yes. Alexander disease can begin in adulthood. Adult-onset disease often has different neurological features from the infantile form and may progress more slowly.
Alexander disease is one of several leukodystrophies, but it is specifically associated with pathogenic variants in the GFAP gene and abnormalities involving astrocytes. Genetic testing and characteristic MRI findings can help distinguish it from other white-matter disorders.
Medical Disclaimer: This article is intended for general educational and informational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Anyone experiencing symptoms suggestive of Alexander disease should consult a qualified healthcare professional.
